5 results match your criteria Procedia in Vaccinology [Journal]

  • Page 1 of 1

Haloarchaeal gas vesicle nanoparticles displaying antigens as a novel approach to vaccine development.

Procedia Vaccinol 2015;9:16-23

University of Maryland School of Medicine, USA.

A safe, effective, and inexpensive vaccine against typhoid and other diseases is urgently needed. In order to address this need, we are developing a novel vaccine platform employing buoyant, self-adjuvanting gas vesicle nanoparticles (GVNPs) from the halophilic archaeon sp. NRC-1, bioengineered to display highly conserved antigens. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.provac.2015.05.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758358PMC
January 2015
16 Reads

Evaluation of a Outer Membrane Vesicle Vaccine in Nonhuman Primates.

Procedia Vaccinol 2014 Jan;8:38-42

Tulane University School of Medicine, New Orleans LA 70112, USA.

()is the causative agent of melioidosis and is endemic in regions of northern Australia and Southeast Asia. is inherently resistant to multiple antibiotics and is considered a potential biological warfare agent by the U.S. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.provac.2014.07.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142560PMC
January 2014
34 Reads

Protective response to subunit vaccination against intranasal and challenge.

Procedia Vaccinol 2010 ;2(1)

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas 77555-1070 ; Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555-1070 ; The Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas 77555-1070.

and are Gram-negative pathogenic bacteria, responsible for the diseases glanders and melioidosis, respectively. Furthermore, there is currently no vaccine available against these species. In this study, we aimed to identify protective proteins against these pathogens. Read More

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S1877282X1000014
Publisher Site
http://dx.doi.org/10.1016/j.provac.2010.03.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874274PMC
January 2010
18 Reads

Multivalent Vaccine for Lymphatic Filariasis.

Procedia Vaccinol 2010 ;3:12-18

Department of Biomedical Sciences, College of Medicine, University of Illinois Rockford, 1601 Parkview Avenue, Rockford, Illinois, USA. 61107.

Lymphatic filariasis is a mosquito borne parasitic infection that cause severe economic burden in several parts of the world. Currently there is no vaccine available to prevent this infection in human. Multidrug therapy is effective, however, requires annual treatment and there is significant concern of drug resistance. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.provac.2010.11.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121258PMC
January 2010
9 Reads

Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles.

Procedia Vaccinol 2010 ;2(1):15-19

School of Chemical and Biomolecular Engineering, Georgia Institute of Technology.

Morbidity and mortality due to seasonal and pandemic influenza could be reduced by simpler vaccination methods that enable improved vaccination coverage. In this study, solid metal microneedles coated with influenza virus-like particle (VLP) vaccine were inserted into skin for intradermal immunization. Microneedles were applied to the skin by hand and designed for simple administration with little or no training. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.provac.2010.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082143PMC
January 2010
15 Reads
  • Page 1 of 1